IP Library Granted Patent US 7,078,406
Granted Patent B2
US 7,078,406 · App. 10/891,259 · Granted Jul 18, 2006

Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes

Assignee: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,078,406
App. No.
10/891,259
Granted
Jul 18, 2006
Kind
B2
Abstract

The present invention is directed to a compound of Formula I: wherein A, R 1 , and R 2 are defined herein. The present invention is also directed to compositions comprising compounds of Formula I, methods of using compounds of Formula I, and methods of making compounds of Formula I.

Claims (23)

1. A method of using a compound of Formula I to monitor an environment, wherein said environment is a cell, said method comprising:

(a) placing said compound in or near said environment;

(b) exposing said compound to a light source, wherein said light source produces light with wavelengths between 200 and 700 nm; and

(c) detecting a fluorescent energy, wherein said fluorescent energy is emitted by said compound; wherein the compound of Formula I is:

wherein

A is a single bond, alkylene, alkenylene, or alkynylene, wherein any of alkylene, alkenylene, and alkynylene is optionally substituted;

R 1 is cycloalkyl, cycloalkenyl, piperazine, pyrrolidine, imidazole, aryl, —OR 3 , —SR 3 , —S(O)R 3 , —S(O) 2 R 3 , —C(O)H, —C(O)OR 3 , —OC(O)R 3 , —C(O)NR 3 R 4 , —NR 3 C(O)R 4 , —OC(O)OR 3 , —OC(O)NR 3 R 4 , NR 3 C(O)OR 4 , —OS(O) 2 OR 3 , —S(O) 2 OR 3 , —S(O)OR 3 , —OP(O)(OR 3 )OR 4 , —P(O)(OR 3 )OR 4 , —P(O)HOR 3 , amidino, guanidino, biguanidino, oxyguanidino, alkyliminoamino, formyliminoamino, or EDTA; and

R 2 is H, alkyl, alkenyl, alkynyl, aryl, arylalkyl, or cycloalkyl, wherein any of alkyl, alkenyl, alkynyl, aryl, arylalkyl, and cycloalkyl is optionally substituted; and

R 3 and R 4 are independently H, alkyl, alkenyl, alkynyl, aryl, or arylalkyl, wherein any of alkyl, alkenyl, alkynyl, aryl, and arylalkyl, is optionally substituted;

or wherein

A is a single bond; and R 1 , R 2 , and A, together with N to which R 1 , R 2 , and A are attached, form a piperazine or thiazolidine, either of which is optionally substituted;

and salts thereof;

with the provisos that, when A is C 1-8 unsubstituted alkyl and R 2 is H or methyl, then R 1 is not —NH 2 , —NHCH 3 , —N(CH 3 ) 2 , or —NHC(O)CH 2 Br;

when A is C 1-3 unsubstituted alkyl and R 2 is H, then R 1 is not —C(O)OH, —C(O)OCH 3 , or —C(O)OCH 2 CH 3 ;

when A is C 1-3 unsubstituted alkyl and R 2 is H, then R 1 is not —NHC(O)C 6 F 5 ;

when A is a single bond and R 2 is H or CH 3 , then R 1 is not phenyl substituted with —B(OH) 2 ; and

when A is a single bond, R 1 , R 2 , and A, together with N to which R 1 , R 2 , and A are attached, do not form unsubstituted morpholinyl.

2. The method of claim 1 , wherein said light source produces light with wavelengths between 300 and 600 nm.

3. The method of claim 2 performed as a fluorescence thermal shift assay.

4. The method of claim 2 , wherein said environment is an endoplasmic reticulum of said cell.

5. The method of claim 2 , wherein said compound is used as a hydroxy reactive probe.

6. The method of claim 2 , wherein said compound is used as a amine reactive probe.

7. The method of claim 2 , wherein said compound is used as a ketone reactive probe.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2010
From: JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 025451/0597 →
MERGER Recorded Nov 11, 2010
From: 3-DIMENSIONAL PHARMACEUTICALS, INC.
To: JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C.
Reel/Frame 025351/0202 →
MERGER Recorded Mar 16, 2006
From: 3-DIMENSIONAL PHARMACEUTICALS, INC.
To: JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, L.L.C.
Reel/Frame 017313/0357 →
Continuity (3)
Division 1026711800 · Oct 9, 2002
Provisional Application 6032730700 · Oct 9, 2001
Related Publication 20040248851A1 · Dec 9, 2004